Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...
Abstract: Recently, a new process monitoring and fault diagnosis method based on slow feature analysis has been developed, which enables concurrent monitoring of both operating point and process ...
GopherJS compiles Go code (go.dev) to pure JavaScript code. Its main purpose is to give you the opportunity to write front-end code in Go which will still run in all browsers. Nearly everything, ...
Abstract: Training neural networks with the Moore–Penrose (MP) inverse has recently gained attention in view of its noniterative training nature. However, a significant drawback of learning based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results